Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Azo Compounds | 3 | 2022 | 117 | 1.700 |
Why?
|
Staining and Labeling | 4 | 2022 | 1083 | 1.320 |
Why?
|
Macrophages, Alveolar | 2 | 2022 | 409 | 1.270 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2020 | 748 | 1.190 |
Why?
|
Biopsy, Fine-Needle | 10 | 2024 | 1110 | 0.930 |
Why?
|
Lung Transplantation | 3 | 2022 | 1305 | 0.870 |
Why?
|
Breast Neoplasms | 15 | 2024 | 21017 | 0.740 |
Why?
|
Feedback, Psychological | 1 | 2021 | 95 | 0.730 |
Why?
|
Contusions | 1 | 2021 | 79 | 0.720 |
Why?
|
Foam Cells | 1 | 2020 | 68 | 0.700 |
Why?
|
Biopsy | 6 | 2024 | 6768 | 0.650 |
Why?
|
BRCA2 Protein | 1 | 2023 | 798 | 0.630 |
Why?
|
Coloring Agents | 1 | 2020 | 560 | 0.590 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1147 | 0.560 |
Why?
|
Tonsillar Neoplasms | 1 | 2017 | 50 | 0.560 |
Why?
|
Palatine Tonsil | 1 | 2017 | 193 | 0.540 |
Why?
|
Lymphoma | 2 | 2024 | 1896 | 0.540 |
Why?
|
Triage | 1 | 2023 | 986 | 0.530 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1840 | 0.500 |
Why?
|
Immunoconjugates | 1 | 2022 | 949 | 0.470 |
Why?
|
Lymphoma, Follicular | 3 | 2022 | 453 | 0.450 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1894 | 0.390 |
Why?
|
Rare Diseases | 1 | 2017 | 619 | 0.390 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2024 | 1086 | 0.370 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1721 | 0.360 |
Why?
|
Cytodiagnosis | 3 | 2024 | 442 | 0.340 |
Why?
|
Granulomatous Mastitis | 2 | 2019 | 7 | 0.310 |
Why?
|
Flow Cytometry | 3 | 2022 | 5864 | 0.310 |
Why?
|
Sarcoidosis | 1 | 2014 | 520 | 0.310 |
Why?
|
Patient Care Planning | 1 | 2013 | 907 | 0.290 |
Why?
|
Receptor, erbB-2 | 4 | 2023 | 2553 | 0.290 |
Why?
|
Macrophages | 1 | 2022 | 5737 | 0.280 |
Why?
|
PTEN Phosphohydrolase | 2 | 2023 | 1113 | 0.260 |
Why?
|
Hematologic Neoplasms | 1 | 2017 | 1890 | 0.250 |
Why?
|
Lung | 4 | 2022 | 9985 | 0.240 |
Why?
|
Attitude to Health | 1 | 2013 | 2025 | 0.230 |
Why?
|
Telepathology | 1 | 2024 | 77 | 0.220 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2023 | 936 | 0.220 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2023 | 124 | 0.200 |
Why?
|
Humans | 52 | 2024 | 758381 | 0.200 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2023 | 1096 | 0.200 |
Why?
|
Immunohistochemistry | 6 | 2023 | 11070 | 0.190 |
Why?
|
Neoplasms | 3 | 2022 | 22030 | 0.190 |
Why?
|
Receptors, Estrogen | 4 | 2019 | 2211 | 0.180 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 132 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2023 | 187 | 0.170 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 129 | 0.170 |
Why?
|
Cytological Techniques | 1 | 2021 | 218 | 0.170 |
Why?
|
Tracheal Stenosis | 1 | 2022 | 226 | 0.170 |
Why?
|
Carcinoid Tumor | 1 | 2021 | 228 | 0.170 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2551 | 0.170 |
Why?
|
Female | 28 | 2024 | 390316 | 0.160 |
Why?
|
Lymph Nodes | 2 | 2021 | 3485 | 0.150 |
Why?
|
Gene Amplification | 1 | 2022 | 1085 | 0.150 |
Why?
|
Fungi | 1 | 2020 | 339 | 0.140 |
Why?
|
Breast Neoplasms, Male | 1 | 2019 | 221 | 0.140 |
Why?
|
Checklist | 1 | 2024 | 827 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 447 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2019 | 345 | 0.140 |
Why?
|
Ascaris suum | 1 | 2016 | 10 | 0.140 |
Why?
|
Frozen Sections | 1 | 2017 | 153 | 0.130 |
Why?
|
Middle Aged | 13 | 2023 | 219560 | 0.130 |
Why?
|
Observer Variation | 2 | 2020 | 2600 | 0.130 |
Why?
|
Trachea | 1 | 2022 | 1081 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2019 | 555 | 0.130 |
Why?
|
Optic Nerve Glioma | 1 | 2015 | 32 | 0.130 |
Why?
|
Patient Care | 1 | 2021 | 622 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 895 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2019 | 375 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 2017 | 343 | 0.120 |
Why?
|
Airway Obstruction | 1 | 2020 | 661 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 215 | 0.120 |
Why?
|
Erythema Nodosum | 1 | 2014 | 31 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Tonsillectomy | 1 | 2017 | 268 | 0.110 |
Why?
|
Intubation, Intratracheal | 1 | 2022 | 1327 | 0.110 |
Why?
|
Prognosis | 6 | 2024 | 29558 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2023 | 2504 | 0.110 |
Why?
|
Young Adult | 6 | 2021 | 58808 | 0.110 |
Why?
|
Aged | 10 | 2023 | 168217 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 384 | 0.110 |
Why?
|
Sweating | 1 | 2014 | 154 | 0.110 |
Why?
|
Adult | 11 | 2023 | 219916 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1612 | 0.100 |
Why?
|
Carcinoma, Lobular | 1 | 2016 | 489 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2014 | 319 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2016 | 0.100 |
Why?
|
Receptors, Progesterone | 1 | 2016 | 1130 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2523 | 0.100 |
Why?
|
Mastectomy, Segmental | 1 | 2016 | 972 | 0.090 |
Why?
|
Lipids | 1 | 2022 | 3326 | 0.090 |
Why?
|
Male | 12 | 2022 | 358742 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2129 | 0.090 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 532 | 0.090 |
Why?
|
Neurofibromatosis 1 | 1 | 2015 | 560 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2014 | 546 | 0.090 |
Why?
|
Stromal Cells | 1 | 2015 | 1326 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58681 | 0.090 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3840 | 0.090 |
Why?
|
Bronchi | 1 | 2014 | 848 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2022 | 80170 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1516 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7377 | 0.080 |
Why?
|
Leiomyosarcoma | 1 | 2013 | 424 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1724 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16534 | 0.080 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13245 | 0.080 |
Why?
|
Leiomyoma | 1 | 2013 | 654 | 0.080 |
Why?
|
Bronchoscopy | 1 | 2014 | 910 | 0.070 |
Why?
|
Astrocytes | 1 | 2015 | 1337 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3774 | 0.070 |
Why?
|
Abdominal Pain | 1 | 2014 | 1063 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 938 | 0.070 |
Why?
|
Child, Preschool | 3 | 2020 | 42058 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1906 | 0.070 |
Why?
|
Microglia | 1 | 2015 | 1349 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3709 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5349 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14641 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1346 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4317 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2011 | 1630 | 0.060 |
Why?
|
Psoriasis | 1 | 2014 | 938 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8506 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9273 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12951 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5248 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2013 | 1439 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4048 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2215 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3615 | 0.050 |
Why?
|
Adolescent | 4 | 2020 | 87888 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Genes, erbB-2 | 1 | 2023 | 162 | 0.050 |
Why?
|
Mice, SCID | 2 | 2020 | 2626 | 0.050 |
Why?
|
United States | 4 | 2024 | 72140 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 17768 | 0.050 |
Why?
|
Child | 3 | 2020 | 79813 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5797 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3443 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3574 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11709 | 0.050 |
Why?
|
Axilla | 1 | 2023 | 626 | 0.050 |
Why?
|
Infant | 2 | 2020 | 36054 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2024 | 583 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9405 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2019 | 6127 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3783 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 651 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39060 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2023 | 733 | 0.040 |
Why?
|
Risk Factors | 2 | 2023 | 73806 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 983 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2024 | 1121 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54136 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 850 | 0.040 |
Why?
|
Societies, Medical | 2 | 2024 | 3891 | 0.040 |
Why?
|
DNA, Viral | 1 | 2024 | 2194 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 41252 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1303 | 0.040 |
Why?
|
Hydrogels | 1 | 2023 | 723 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1676 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20052 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2024 | 1489 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2022 | 1871 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.030 |
Why?
|
RNA, Helminth | 1 | 2016 | 60 | 0.030 |
Why?
|
Purines | 1 | 2019 | 605 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 564 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 2943 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1660 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11152 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4312 | 0.030 |
Why?
|
Mice, Nude | 1 | 2019 | 3602 | 0.030 |
Why?
|
Breast | 1 | 2022 | 1963 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2022 | 1669 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 963 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2016 | 681 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1165 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3617 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
Animals | 6 | 2023 | 167777 | 0.030 |
Why?
|
Pandemics | 2 | 2024 | 8611 | 0.020 |
Why?
|
Hospitals, General | 1 | 2016 | 795 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2014 | 480 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 507 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15225 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1955 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2470 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11336 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2312 | 0.020 |
Why?
|
Mice | 4 | 2020 | 81107 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3867 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1825 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2385 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2024 | 2882 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2015 | 1674 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25953 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1530 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7199 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1791 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4567 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 748 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5031 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6154 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5484 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1740 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2024 | 8946 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6493 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5779 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2751 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12436 | 0.020 |
Why?
|
Cell Cycle | 1 | 2013 | 2930 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5331 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10417 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9468 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8554 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8823 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12760 | 0.010 |
Why?
|
Image Enhancement | 1 | 2011 | 2880 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2011 | 2083 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11894 | 0.010 |
Why?
|
Contrast Media | 1 | 2011 | 5298 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16886 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22006 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13959 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39873 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26182 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64379 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8981 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 29915 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20500 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36285 | 0.000 |
Why?
|